Mike Foley, a drug industry veteran and director of the Tri-Institutional Therapeutics Discovery Institute, has a pointed message for the New York life sciences industry: Don’t waste the moment. Changing the course of New York biotech has been a saga that dates back to the 1990s, and as Xconomy has detailed, progress has been made […]
NYS Entity Status
NYS Filing Date
APRIL 16, 2014
NYS DOS ID#
CT CORPORATION SYSTEM
111 EIGHTH AVENUE
NEW YORK, NEW YORK, 10011
NYS Entity Type
FOREIGN BUSINESS CORPORATION
2014 - BRANDON POINT INDUSTRIES (US), INC.
Around the Web
- “It’s Shame On Us If We Blow It”: Highlights From NY Seizes the Momentum
By Ben Fidler - Wednesday Jun 7, 2017
- Women of Sex Tech, Unite
By ANNA NORTH - Friday Aug 18, 2017
New York is becoming a cultural center for young women trying to disrupt the male-dominated industries of design engineering and sex toys.
- Brandon Marshall’s Giants plan has gone all wrong
By Greg Joyce - Wednesday Oct 4, 2017
When Brandon Marshall signed with the Giants in March, it was a move aimed at winning, not reeling in the dollars. “They definitely didn’t offer me the most money — it was probably the least amount of money,’’ Marshall said at the time. “It was all about championships, to get straight to the point. They...
- The Look: New York City Parks in the Summer: Romance, Games and a Performance for a Dying Tree
By DANIEL ARNOLD, JOANNA NIKAS and EVE LYONS - Saturday Sep 2, 2017
Daniel Arnold spent the last two months photographing parks in all five boroughs. The experience showed him “a very different pulse of the city.”
- Brandon Marshall isn’t going to give us what Giants-Jets needs
By Mike Vaccaro - Tuesday Aug 8, 2017
Brandon Marshall took a pass on answering the verbal volley lobbed Tuesday by Sheldon Richardson. This is surprising only if you just happened to land in New York 15 minutes ago, because the way Marshall does business now is the way the Giants do business. And that means there was a better chance the Giants...